E09.311
BillableDrug or chemical induced diabetes mellitus with unspecified diabetic retinopathy with macular edema
HCC Category Mapping
What This Code Means
Diabetes caused by medications or chemicals with eye damage (retinopathy) of unspecified type that includes swelling in the macula (central vision area).
Coding Tips
- •Confirm with provider whether the retinopathy type is truly unspecified or if it can be more specifically classified
- •The presence of macular edema indicates more advanced eye disease requiring close monitoring
Clinical Significance
Drug or chemical induced diabetes mellitus with unspecified diabetic retinopathy with macular edema represents drug-induced diabetes that has caused retinal damage with fluid accumulation in the macula, the area responsible for central vision. Macular edema is a vision-threatening complication that may require anti-VEGF injections, laser treatment, or corticosteroid therapy. The 'unspecified' retinopathy designation indicates the severity stage (nonproliferative vs. proliferative) has not been documented.
Documentation Requirements
- ✓The causative drug or chemical must be identified.
- ✓Ophthalmologic examination findings should document the presence of macular edema with optical coherence tomography or fluorescein angiography results.
- ✓The provider should specify the retinopathy stage (mild/moderate/severe nonproliferative or proliferative) to allow more specific code selection.
- ✓Laterality should also be documented.